BRISTOL-MYERS SQUIBB COMPANY Income Taxes Receivable, Current
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Income Taxes Receivable, Current of $159.00 million as of 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Notes › and Others
us-gaap:IncomeTaxesReceivable · last filed 2019-10-31
- 2019-09-30: Income Taxes Receivable, Current $159.00M.
- 2019-06-30: Income Taxes Receivable, Current $166.00M.
- 2019-03-31: Income Taxes Receivable, Current $158.00M.
- 2018-12-31: Income Taxes Receivable, Current $218.00M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2019-09-30 | $159.00M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $166.00M 10-Q · filed 2019-07-25 |
| 2019-03-31 | $158.00M 10-Q · filed 2019-04-25 |
| 2018-12-31 | $218.00M 10-Q · filed 2019-10-31 |
| 2018-09-30 | $180.00M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $170.00M 10-Q · filed 2018-07-26 |
| 2018-03-31 | $325.00M 10-Q · filed 2018-04-26 |
| 2017-12-31 | $691.00M 10-K · filed 2019-02-25 |
| 2017-09-30 | $334.00M 10-Q · filed 2017-10-26 |
| 2017-06-30 | $318.00M 10-Q · filed 2017-07-27 |
| 2017-03-31 | $243.00M 10-Q · filed 2017-04-27 |
| 2016-12-31 | $627.00M 10-K · filed 2018-02-13 |
| 2016-09-30 | $444.00M 10-Q · filed 2016-10-27 |
| 2016-06-30 | $483.00M 10-Q · filed 2016-07-28 |
| 2016-03-31 | $207.00M 10-Q · filed 2016-04-28 |
| 2015-12-31 | $182.00M 10-K · filed 2017-02-21 |
| 2015-09-30 | $175.00M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $159.00M 10-Q · filed 2015-07-23 |
| 2015-03-31 | $118.00M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $178.00M 10-K · filed 2016-02-12 |
| 2014-09-30 | $144.00M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $290.00M 10-Q · filed 2014-07-24 |
| 2014-03-31 | $283.00M 10-Q · filed 2014-04-29 |
| 2013-12-31 | $262.00M 10-K · filed 2015-02-13 |
| 2013-09-30 | $310.00M 10-Q · filed 2013-10-23 |
| 2013-06-30 | $357.00M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $336.00M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $319.00M 10-K · filed 2014-02-14 |
| 2012-09-30 | $202.00M 10-Q · filed 2012-10-24 |
| 2012-06-30 | $146.00M 10-Q · filed 2012-07-25 |
| 2012-03-31 | $244.00M 10-Q · filed 2012-04-26 |
| 2011-12-31 | $256.00M 10-K · filed 2013-02-15 |
| 2011-09-30 | $271.00M 10-Q · filed 2011-10-27 |
| 2011-06-30 | $426.00M 10-Q · filed 2011-07-28 |
| 2011-03-31 | $198.00M 10-Q · filed 2011-04-28 |
| 2010-12-31 | $223.00M 10-K · filed 2012-02-17 |
| 2010-09-30 | $175.00M 10-Q · filed 2010-10-26 |
| 2010-06-30 | $190.00M 10-Q · filed 2010-07-22 |
| 2009-12-31 | $103.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |